Supernus Pharmaceuticals
SUPN
#4208
Rank
NZ$3.74 B
Marketcap
$67.88
Share price
2.23%
Change (1 day)
46.18%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.25

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.39. In 2022 the company made an earnings per share (EPS) of $1.99 an increase over its 2021 EPS that were of $1.79.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.25-36.93%
2022$1.9910.78%
2021$1.79-57.68%
2020$4.2412.09%
2019$3.780.47%
2018$3.7789.38%
2017$1.99-38.59%
2016$3.24534.48%
2015$0.51-211.54%
2014-$0.46-91.1%
2013-$5.1439.46%
2012-$3.68-69.27%
2011-$11.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$33.99 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.55 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.98 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.23 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.78 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA